DV
Dividend Vision

BNGO Stock — Bionano Genomics Inc

Bionano Genomics Inc (BNGO)

Updated November 17, 2026.

BNGO is a stock. Total return is -100.0% over the past 8.2 years, 288.7 points behind SPY at 188.7%.

Bionano Genomics develops and commercializes genome analysis solutions, including optical genome mapping systems, software, and laboratory testing services for identifying genetic variations and diagnosing genetic disorders across multiple markets globally. The company does not currently distribute dividends. This operating company appeals primarily to growth-oriented investors focused on the genomics and molecular diagnostics sector rather than those seeking dividend income.

BNGO performance versus SPY

Total return is -100.0% over the past 8.2 years, 288.7 points behind SPY at 188.7%. Over the past year its total return — price change plus distributions reinvested — is -37.0%. Its deepest 1-year drawdown was 49.2%.

WindowTotal returnCAGR
1M-21.9%—
3M-17.3%—
6M-15.9%—
YTD-36.2%—
1Y-37.0%—
2Y CAGR—-73.40%
3Y CAGR—-77.00%
5Y CAGR—-79.40%
Since inception 2018-08-21 · 8.2 years-100.0%-63.20%

BNGO key facts

Asset type
Stock
Asset class
Equity
Inception date
08/21/2018
Distribution frequency
None
Last close
$0.95 (as of 2026-11-17)
Market cap
$13,318,927
Average volume
71,848
Beta
1.708
Payout ratio
0.0%
EPS
-$3.02

How Dividend Vision calculates returns

Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BNGO risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 49.2%.

Who may consider BNGO — and who may not

It is a weaker fit for investors who need monthly cash flow (BNGO does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BNGO

Tagged: Healthcare.

Frequently asked questions

Does BNGO pay monthly?

No. BNGO does not currently distribute.

When does BNGO pay a dividend?

BNGO does not currently distribute.

How has BNGO performed?

Total return is -100.0% over the past 8.2 years, 288.7 points behind SPY at 188.7%. Over the past year its total return — price change plus distributions reinvested — is -37.0%. Its deepest 1-year drawdown was 49.2%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.